EARLIER IDENTIFICATION AND EARLY INTERVENTION FOR CHILDREN WHO ARE DEAF OR HARD OF HEARING
With
Professor Greg Leigh AO, Director
NextSense Institute, Australia &
Conjoint Professor, Macquarie School of Education
Macquarie University, Sydney
RESEARCHER PROFILE
Filmed in Sydney, Australia | June 2025
As Director of NextSense Institute, Professor Leigh is responsible for leading the not-for-profit organisation’s world-class research and education programs and facilities.
Professor Leigh held a variety of positions in the education of children who are deaf or hard of hearing before entering academia. He holds a degree in Special Education from Griffith University, a Master of Science (Speech and Hearing) from Washington University and a PhD in Special Education from Monash University. In 2001, he was made a Fellow of the Australian College of Educators and in 2014, he was invested as an Officer in the Order of Australia (AO) for distinguished services to the deaf and hard of hearing community.
He is a member of the Editorial Board of The Journal of Deaf Studies and Deaf Education and has researched widely on issues related to the early development and education of children who are deaf or hard of hearing.
A former National President of the Education Commission for the World Congress of the World Federation of the Deaf, Professor Leigh has also Chaired the International Steering Committees of both the Asia-Pacific Congress on Deafness (APCD) and the International Congress on Education of the Deaf (ICED).
He has served on several Australian Government consultative committees, including the New South Wales Ministerial Standing Committee on Hearing, the National Neonatal Hearing Screening Working Party, and the Key Scientists Committee of the Hearing Cooperative Research Centre.
For the last 19 years, Professor Leigh has chaired the Australasian Newborn Hearing Screening Committee.
In his spare time, Professor Leigh is an active member/supporter of the Sydney Swans Football Club, and he and his wife enjoy symphonic music. He is also actively involved in the work of the St Vincent de Paul Society as a volunteer for the Vinnie’s Van program.
Source: Supplied
-
Systems genetics to determine risk of developing diabetes complications
Dr Mara Zeissig is a recently appointed Lab Head within the Tumour Inflammation and Immunotherapy Program at the South Australian immunoGENomics Cancer Institute (SAiGENCI).
Her research focuses on studying immune evasion mechanisms in lung and pancreatic cancers to identify novel ways to increase response to immunotherapy. Her expertise is in genetically engineered mouse models of lung cancer, CRISPR-Cas9 screening technologies and T cell based immunotherapies (e.g Checkpoint inhibitors). -
Biomarkers for early sepsis detection
Dr Gabrielle Briggs is a biomedical scientist dedicated to finding smarter, faster ways to diagnose and treat life threatening complications in critically ill patients. Dr Briggs established a research laboratory embedded within the John Hunter Hospital – one of the busiest major trauma centres in NSW. Dr Briggs works alongside surgeons, intensivists, and pathologists to turn complex clinical problems into practical research solutions. Her work spans two major programs: developing a rapid diagnostic test to detect bacterial infections in blood before sepsis takes hold, and exploring mitochondrial transplantation as a novel therapy to rescue injured tissues after trauma and ischaemia.
-
Seeking discoveries in earlier bowel cancer detection
Associate Professor Susan Woods is a cancer research focused on eradicating bowel cancer through earlier detection and investigating the DNA related from colorectal cancer cells. She leads the Gut Cancer Research Group at the University of Adelaide and SAHMRI and with her team is researching new treatments for advanced disease.
